Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing Olaparib listed in the FDA Orange Book. Original Data : FDA Website

Client Email

Product

Olaparib
763114-04-1
CAS 1759-53-1
763111-47-3
FDA Orange Book

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Olaparib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 11 USDMF, 3 EU WC, 3 KDMF, 10 NDC API, 21 Listed Suppliers, $ API Reference Price

29 API Suppliers
11 USDMF
3 EU WC
3 KDMF
10 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

70 Drugs in Development

70 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

29 API Suppliers

29 API Suppliers

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 3 FDA Orange Book, 7 Europe, 2 Canada, 20 Australia, 2 South Africa, 6 Listed Dossiers

40 FDF Dossiers
3 FDA Orange Book
7 Europe
2 Canada
20 Australia
2 South Africa
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 13 SPI Pharma, 4 DKSH, 1 Jai Radhe Sales, 2 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 2 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 2 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Finar, 6 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 1 NEWEDGE Overseas, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 5 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 18 Controlled & Modified Release, 17 Direct Compression, 14 Film Formers & Plasticizers, 13 Chewable & Orodispersible Aids, 12 Taste Masking, 8 Lubricants & Glidants, 7 Disintegrants & Superdisintegrants, 7 Granulation, 6 Thickeners and Stabilizers, 6 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 5 Solubilizers, 5 Topical, 4 Co-Processed Excipients, 4 Vegetarian Capsules, 4 Emulsifying Agents, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents

46 Coating Systems & Additives
30 Fillers, Diluents & Binders
18 Controlled & Modified Release
17 Direct Compression
14 Film Formers & Plasticizers
13 Chewable & Orodispersible Aids
12 Taste Masking
8 Lubricants & Glidants
7 Disintegrants & Superdisintegrants
7 Granulation
6 Thickeners and Stabilizers
6 Parenteral
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
5 Solubilizers
5 Topical
4 Co-Processed Excipients
4 Vegetarian Capsules
4 Emulsifying Agents
2 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 3 STOCK RECAP #PipelineProspector, 269 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
3 STOCK RECAP #PipelineProspector
269 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 15 Annual Reports

1 US Medicaid Prescriptions
4 Finished Drug Prices
15 Annual Reports

MARKET PLACE

8 APIs, 5 FDF Dossiers

8 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

148 US Patents, 14 US Exclusivities, 4 Health Canada Patents

148 US Patents
14 US Exclusivities
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

13 Others

13 Others

$ API Ref.Price (USD/KG) : 7,761 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3ASTRAZENECA

filter Dosage Reset all filters

3 All

01 1CAPSULE;ORAL

02 2TABLET;ORAL

filter Regulatory Info Reset all filters

3 All

01 1DISCN

02 2RX

filter Brand Name Reset all filters

3 All

01 3LYNPARZA

filter RLD Reset all filters

3 All

01 3Yes

Axplora Olaparib

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

ASTRAZENECA

Fall Technical Meeting

Not Confirmed

ASTRAZENECA

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : LYNPARZA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG

Approval Date : 2014-12-19

Application Number : 206162

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ASTRAZENECA

Fall Technical Meeting

Not Confirmed

ASTRAZENECA

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : LYNPARZA

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Approval Date : 2017-08-17

Application Number : 208558

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ASTRAZENECA

Fall Technical Meeting

Not Confirmed

ASTRAZENECA

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : LYNPARZA

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Approval Date : 2017-08-17

Application Number : 208558

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?